Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2024 Oct;47(10):e70020.
doi: 10.1002/clc.70020.

Association Between Overweight/Obesity Metabolic Phenotypes Defined by Two Criteria of Metabolic Abnormality and Cardiovascular Diseases: A Cross-Sectional Analysis in a Chinese Population

Yue Qiu  1   2 , Shujin Fan  1   2 , Jing Liu  1   2 , Xiaodan He  1   2 , Tianxin Zhu  1   2 , Li Yan  1   2 , Meng Ren  1   2
Affiliations
Multicenter Study

Association Between Overweight/Obesity Metabolic Phenotypes Defined by Two Criteria of Metabolic Abnormality and Cardiovascular Diseases: A Cross-Sectional Analysis in a Chinese Population

Yue Qiu et al. Clin Cardiol. 2024 Oct.

Abstract

Objectives: Obesity/overweight and metabolic anomalies are known to be associated with elevated cardiovascular disease (CVD) risk. However, there is a paucity of research exploring the association between different body weights, varying metabolic statuses, and the occurrence of CVD in the Chinese population. Thus, we performed this study to explore the relation between different metabolic overweight/obesity phenotypes and the prevalence of CVD.

Methods: We analyzed data from 9075 participants in the Risk Evaluation of cAncers in Chinese diabeTic Individuals: A lONgitudinal (REACTION) study. Participants were classified into four metabolic phenotypes based on their metabolic status and obesity/overweight status. Regression analysis was used to evaluate the relationship between CVD and different groups. Additionally, we conducted a subgroup analysis to further explore the relationship between CVD and different metabolic abnormalities.

Results: Compared to metabolically healthy non-overweight/obesity (MHNO) individuals, both overweight/obesity and metabolic anomalies were positively associated with CVD prevalence. Among other metabolically unhealthy and overweight/obesity phenotypes, metabolically healthy overweight/obesity (MHO) generally exhibited a comparatively lower association with CVD. In the elderly, high waist circumference was significantly associated with CVD, rather than body weight. Further analysis revealed that hypertension had the strongest association with CVD.

Conclusion: Elderly individuals should place more emphasis on managing their waist circumference rather than only on BMI. CVD prevention should focus on both body weight management and treatment of metabolic diseases, with particular emphasis on antihypertensive therapy.

Keywords: cardiovascular disease; metabolic; obesity; phenotype.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Flowchart for selection of study participants. BMI, body mass index; CVD, cardiovascular disease; DBP, diastolic blood pressure; FBG, fasting blood glucose; HDL‐C, high‐density lipoprotein cholesterol; MHNO, metabolically healthy non‐overweight/obesity; MHO, metabolic healthy overweight/obesity; MUNO, metabolically unhealthy non‐overweight/obesity; MUO, metabolic unhealthy overweight/obesity; SBP, systolic blood pressure; TG, triglycerides; WC, waist circumference.
See this image and copyright information in PMC

References

    1. Naghavi M., Wang H., Lozano R., et al., “Global, Regional, and National Age‐Sex Specific All‐Cause and Cause‐Specific Mortality for 240 Causes of Death, 1990–2013: A Systematic Analysis for the Global Burden of Disease Study 2013,” Lancet 385, no. 9963 (2015): 117–171, 10.1016/S0140-6736(14)61682-2. - DOI - PMC - PubMed
    1. Vos T., Lim S. S., Abbafati C., et al., GBD 2019 Diseases and Injuries Collaborators , “Global Burden of 369 Diseases and Injuries in 204 Countries and Territories, 1990–2019: A Systematic Analysis for the Global Burden of Disease Study 2019,” Lancet 396, no. 10258 (2020): 1204–1222, 10.1016/S0140-6736(20)30925-9. - DOI - PMC - PubMed
    1. Roth G. A., Mensah G. A., Johnson C. O., et al., “Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019: Update From the GBD 2019 Study,” Journal of the American College of Cardiology 76, no. 25 (2020): 2982–3021, 10.1016/j.jacc.2020.11.010. - DOI - PMC - PubMed
    1. Zhao D., Liu J., Wang M., Zhang X., and Zhou M., “Epidemiology of Cardiovascular Disease in China: Current Features and Implications,” Nature Reviews Cardiology 16, no. 4 (2019): 203–212, 10.1038/s41569-018-0119-4. - DOI - PubMed
    1. Chartrand D. J., Murphy‐Després A., Alméras N., Lemieux I., Larose E., and Després J.‐P., “Overweight, Obesity, and CVD Risk: A Focus on Visceral/Ectopic Fat,” Current Atherosclerosis Reports 24, no. 4 (2022): 185–195, 10.1007/s11883-022-00996-x. - DOI - PubMed

Publication types

MeSH terms

LinkOut - more resources